FORM 4
[X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Lightcap Jeffrey C		 2. Issuer Name and Ticker or Trading Symbol

Corindus Vascular Robotics, Inc. [ CVRS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

701 EAST BAY STREET, SUITE 516		 3. Date of Earliest Transaction (MM/DD/YYYY)

10/29/2019
(Street)

CHARLESTON, SC 29403
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  10/29/2019    J(1)    32500478  D $4.28  0  I  See Footnote (2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Disposed of pursuant to merger agreement by and among Issuer, Siemens Medical Solutions USA, Inc. and Corpus Merger, Inc., for a cash payment of the per share price noted.
(2)  Consists of 17,090,941 shares held directly by HealthCor Partners Fund, L.P. ("HCP") and 15,409,537 shres held directly by HealthCor Partners Fund II, L.P. ("HCPII"). The shares held by HCP may be deemed to be beneficially owned by HealthCor Partners, L.P. ("HCPLP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCPLP. The shares held by HCPII may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HCPGP, the general partner of of HCP2LP. Mr. Lightlcap is a managing member of HCPGP and may be deemed to have shared voting and investment power over such shares. Each of HCPLP, HCP2LP, HCPGP, and Mr. Lightcap hereby disclaims any beneficial ownership of shares held by HCP or HCPII except to the extent of any pecuniary interest therein. The record and other beneficial owners have separately filed a Form 4 to reflect the disposition in the merger.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Lightcap Jeffrey C
701 EAST BAY STREET, SUITE 516
CHARLESTON, SC 29403 		X X


Signatures
/s/ Anabelle Gray, as attorney in fact 10/31/2019
**Signature of Reporting Person Date


Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Corindus Vascular Robotics Charts.
Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Corindus Vascular Robotics Charts.
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....